<DOC>
	<DOC>NCT00811330</DOC>
	<brief_summary>The purpose of the study is to see if statin therapy will optimize myocardial response to cardiopulmonary bypass during aortic valve replacement (AVR) for aortic valve stenosis (AVS) (Phase I) and optimize left ventricular reverse remodeling following AVR (Phase II). Preliminary evidence indicates that perioperative statin therapy reduce mortality and morbidity following cardiac surgery. Pleiotropic effects of statins may induce myocardial preconditioning and optimize myocardial and systemic responses to cardiopulmonary bypass during AVR. Furthermore statin therapy after AVR may contribute to an optimal left ventricular reverse remodeling.</brief_summary>
	<brief_title>Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Age &gt; or = 70 years and &lt; 80 years Severe aortic valve stenosis Indication for aortic valve replacement by bioprothesis Ejection fraction &gt; or = 50% Without treatment with statin No renal failure Informed consent signed Ischemic heart disaese Concomitant surgery to aortic valve replacement Emergency surgery Known intolerance for statin Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Left ventricular hypertrophy</keyword>
	<keyword>Aortic valve stenosis</keyword>
	<keyword>Aortic valve replacement</keyword>
	<keyword>Cardiopulmonary bypass</keyword>
	<keyword>Statins</keyword>
	<keyword>Myocardial preconditioning</keyword>
	<keyword>Left ventricular reverse remodeling</keyword>
</DOC>